Since Sp1 activity is an endogenous anti-inflammatory mechanism, this result suggests that NF-κB activation can promotes lung inflammation by suppressing Sp1-mediated anti-inflammatory mechanisms. The gene discussed is SP1; the disease is inflammatory response.